GPT-Rosalind (OpenAI) vs Devin
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
Devin
The most autonomous AI coding agent -- Devin 2.2 (Feb 24 2026) adds desktop/GUI testing (Figma, browser automation), Devin Review (pull-request analysis catching ~30% more issues), and ~3x faster startup (~15s vs ~45s). Now embedded in Windsurf 2.0
Powered by Cognition proprietary orchestration over Claude / GPT / Gemini + Devin's own tuned components
| Category | GPT-Rosalind (OpenAI) | Devin |
|---|---|---|
| Ease of Use | 3.0 | 6.5 |
| Output Quality | 9.0 | 8.0 |
| Value | 7.0 | 7.0 |
| Features | 8.0 | 8.0 |
| Overall | 6.8 | 7.4 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | Devin |
|---|---|---|
| Free Tier | No | No |
| Starting Price | Invite only | $20 |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
- ✓Higher output quality (9 vs 8)
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick Devin if...
- ✓Easier to use (6.5 vs 3)
Development teams that want to offload well-scoped tasks like bug fixes, test writing, and boilerplate code to an autonomous agent. Best when the task description is detailed and specific.
Visit DevinOur Verdict
Devin edges out GPT-Rosalind (OpenAI) with a 7.4 vs 6.8 overall score. Both are solid picks, but Devin has the advantage in features.